8-144054690-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_017570.5(OPLAH):c.2557C>T(p.Arg853Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000236 in 1,612,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
OPLAH
NM_017570.5 stop_gained
NM_017570.5 stop_gained
Scores
4
1
1
Clinical Significance
Conservation
PhyloP100: 4.91
Genes affected
OPLAH (HGNC:8149): (5-oxoprolinase, ATP-hydrolysing) The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144054690-G-A is Pathogenic according to our data. Variant chr8-144054690-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 572337.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPLAH | NM_017570.5 | c.2557C>T | p.Arg853Ter | stop_gained | 19/27 | ENST00000618853.5 | NP_060040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPLAH | ENST00000618853.5 | c.2557C>T | p.Arg853Ter | stop_gained | 19/27 | 1 | NM_017570.5 | ENSP00000480476 | P1 | |
OPLAH | ENST00000531027.1 | n.190C>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
OPLAH | ENST00000527993.1 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152082Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
2
AN:
152082
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247650Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134898
GnomAD3 exomes
AF:
AC:
2
AN:
247650
Hom.:
AF XY:
AC XY:
0
AN XY:
134898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000247 AC: 36AN: 1460268Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 726388
GnomAD4 exome
AF:
AC:
36
AN:
1460268
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
726388
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 29 AF XY: 0.0000134 AC XY: 1AN XY: 74404
GnomAD4 genome
AF:
AC:
2
AN:
152200
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
5-Oxoprolinase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 16, 2018 | This sequence change creates a premature translational stop signal (p.Arg853*) in the OPLAH gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs543486699, ExAC 0.01%). This variant has not been reported in the literature in individuals with OPLAH-related disease. Loss-of-function variants in OPLAH are known to be pathogenic (PMID: 21651516). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at